Close
Digital Health & Ai Innovation summit 2026
LiGHT26

GE HealthCare Completes $2.3B Intelerad Acquisition Deal

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Saint Peterโ€™s Healthcare System Advances Patient...

Saint Peter's Healthcare System in New Brunswick, NJ, has...

CMS Outlines Stricter Anti-Fraud Measures in...

The Centers for Medicare and Medicaid Services (CMS) unveiled...

Sterilization Technologies Improving Medical Device Safety

Advanced sterilization methodologies and rigorous validation protocols ensure patient safety by effectively eliminating microbial contaminants from complex medical instrumentation and single-use devices.

GE HealthCare confirmed it has completed its previously announced $2.3 billion acquisition of Intelerad, marking the completion of a transaction first disclosed in November. The Chicago-based company had outlined at the time that the Intelerad acquisition would be executed as an all-cash deal and aligned with its broader strategy to expand its portfolio of cloud-enabled products threefold by 2028.

Intelerad, known for its imaging software and digital enterprise workflow solutions, operates extensively across outpatient ambulatory care environments. Its portfolio includes cloud-first platforms tailored for both radiology and cardiology, supporting workflows across inpatient and outpatient settings. Through the Intelerad acquisition, GE HealthCare is positioning itself to deepen its footprint in specialized clinics and ambulatory care, while reinforcing its established capabilities in hospital-based imaging. The combined offering is expected to deliver a unified, cloud-first and AI-enabled imaging ecosystem aimed at lowering infrastructure costs and accelerating deployment timelines.

Following the close of the transaction, Intelerad will be integrated into GE HealthCareโ€™s imaging business while continuing to serve enterprise imaging customers across the U.S., Canada, the UK and Oceania. GE HealthCare projects that Intelerad will generate approximately $270 million in revenue during the first full year under its ownership, with around 90% classified as recurring. The company also expects adjusted EBITDA margins to exceed 30%, alongside low-double-digit annual revenue growth, with further acceleration anticipated over time.

GE HealthCare indicated that the acquisition may have a slightly dilutive effect on adjusted EPS in the near term. However, it expects to counterbalance this through cost efficiencies and achieve a high-single-digit return on invested capital by year five.

Scott Miller, CEO, Solutions for Enterprise Imaging, GE HealthCare, said: Intelerad enhances our ability to deliver a cloud-first enterprise imaging platform at scale. Together, we are connecting imaging across care settings with interoperable, AI-enabled solutions that simplify operations, improve clinical insight, and help our customers deliver more precise, personalized care.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

CMS Outlines Stricter Anti-Fraud Measures in 2027 Home Health Payment Proposal

The Centers for Medicare and Medicaid Services (CMS) unveiled...

Sterilization Technologies Improving Medical Device Safety

Advanced sterilization methodologies and rigorous validation protocols ensure patient safety by effectively eliminating microbial contaminants from complex medical instrumentation and single-use devices.

Cold Chain Systems Protecting Medical Product Quality

Maintaining the integrity of temperature-sensitive pharmaceuticals requires a robust cold chain infrastructure, combining advanced monitoring, specialized logistics, and strict regulatory adherence to ensure patient safety.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป